Cardio Diagnostics, Inc, a biotechnology company making cardiovascular disease prevention and early detection more accessible, personalized and precise, announces the launch of its patent-pending ...
Cardio Diagnostics CDIO, a leader in artificial intelligence-driven precision cardiovascular medicine, has published a potentially revolutionary study in the Journal of the American Heart Association ...
CHICAGO--(BUSINESS WIRE)--Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD ™, an ...
Cardio Diagnostics (NASDAQ: CDIO), an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention and early detection more precise, has ...
inews.co.uk on MSN
I’m a healthy 36-year-old but a longevity test said my heart age is 50
'Longevity is fascinating, but you could listen to 10 different podcasts about it and find conflicting messages', a ...
Add Yahoo as a preferred source to see more of our stories on Google. PrecisionCHD is a clinical blood test combining epigenetic Cardio Diagnostics has signed an agreement with AI-driven business ...
Agreement expands Cardio Diagnostics’ global footprint and supports improved detection and management of coronary heart disease in India. CHICAGO, January 07, 2026--(BUSINESS WIRE)--Cardio Diagnostics ...
Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO) shares are trading higher Tuesday after the company announced its AI-driven molecular heart disease test has received an Innovation Technology contract ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results